Associated Papers
MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.
Hu Y et al.
Pathology International, 2021
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
Heinonen HR et al.
Scientific Reports, 2017
28432313 (PubMed )
Supplement: 41598_2017_1199_MOESM1_ESM.pdf
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Laé M et al.
Oncotarget, 2016
Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N et al.
Genes, Chromosomes & Cancer, 2015
Select a paper to view details